歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗CD22多克隆抗體

產(chǎn)品中心

  • 兔抗CD22多克隆抗體

    規(guī)格:
    數(shù)量:

    購買數(shù)量

    價格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW5014
    • 應(yīng)用 : 僅用于科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫存:35
  • 商品詳情
  • 參考文獻(xiàn)
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品

中文名稱:兔抗CD22多克隆抗體

英文名稱:
Anti-CD22 rabbit polyclonal antibody

別      名:
SIGLEC2; SIGLEC-2

相關(guān)類別: 一抗

儲      存: 冷凍(-20℃)

抗      原: CD22

宿      主: Rabbit

反應(yīng)種屬: Human

標(biāo) 記 物: Unconjugate

克隆類型: rabbit polyclonal

技術(shù)規(guī)格

Background:

The B lymphocyte specific CD22 antigen, also designated B-lymphocyte cell adhesion molecule (BLCAM), sialic acid-binding Ig-like lectin 2 (Siglec-2) and Leu-14, is a type I integral membrane glycoprotein, structurally similar to other cell adhesion molecules (CAMs), which acts as a regulator of B cell signaling. CD22 is expressed as both a cytoplasmic and membrane protein during discrete stages of B cell lymphocyte differentiation. The cytoplasmic form of CD22, expressed early in B cell development, is a useful marker for acute lymphocytic leukemia. The membrane form of CD22 is expressed in mature B cells prior to their differentiation into plasma cells.

Applications:

ELISA, IHC

Name of antibody:

CD22

Immunogen:

Fusion protein of human CD22

Full name:

CD22 molecule

Synonyms:

SIGLEC2; SIGLEC-2

SwissProt:

P20273

IHC positive control:

Human gastric cancer and human thyroid cancer

IHC Recommend dilution:

50-200